Immortalized mouse caput epididymal epithelial (mECap18) cell line recapitulates the in-vivo environment

- Mulhall, Jess E., Trigg, Natalie A., Bernstein, Ilana R., Anderson, Amanda L., Murray, Heather C., Sipilä, Petra, Lord, Tessa, Schjenken, John E., Nixon, Brett, Skerrett-Byrne, David A.

Pharmaco-phosphoproteomic analysis of cancer-associated KIT mutations D816V and V560G

- Murray, Heather C., Miller, Kasey, Dun, Matthew D., Verrills, Nicole M.

Phosphoproteomic analysis of the adaption of epididymal epithelial cells to corticosterone challenge

- Skerrett-Byrne, David A., Stanger, Simone J., Dun, Matthew D., Pang, Terence Y., Nixon, Brett, Trigg, Natalie A., Anderson, Amanda L., Sipilä, Petra, Bernstein, Ilana R., Lord, Tessa, Schjenken, John E., Murray, Heather C., Verrills, Nicole M.

PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma

- Duchatel, Ryan J., Jackson, Evangeline R., Kearney, Padraic S., Jamaluddin, M. Fairuz B., Douglas, Alicia M., Beitaki, Tyrone, McEwen, Holly P., Persson, Mika L., Hocke, Emily A., Jain, Vaibhav, Aksu, Michael, Manning, Elizabeth E., Parackal, Sarah G., Murray, Heather C., Verrills, Nicole M., Hua, Susan, Cairns, Murray J., Alvaro, Frank, Dayas, Christopher V., Dun, Matthew D., Hua, S, de Bock, CE, Colino-Sanguino, Y, Kiltschewskij, Dylan, Valdes-Mora, F, Tsoli, M, Ziegler, DS, Cairns, MJ, Raabe, EH, Vitanza, NA, Hulleman, E, Phoenix, TN, Koschmann, C, Alvaro, F, Findlay, Izac J., Dayas, CV, Tinkle, CL, Wheeler, H, Whittle, JR, Eisenstat, DD, Firestein, R, Mueller, S, Valvi, S, Hansford, JR, Ashley, DM, Mannan, Abdul, Gregory, SG, Kilburn, LB, Nazarian, J, Cain, JE, Dun, MD, Staudt, Dilana E., Thomas, Bryce C., Germon, Zacary P., Laternser, Sandra

Proteomic and phosphoproteomic characterisation of primary mouse embryonic fibroblasts

- Chen, Yanfang, Roselli, Severine, Panicker, Nikita, Brzozowski, Joshua S., Skerrett-Byrne, David A., Murray, Heather C., Verrills, Nicole M.

Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies

- Germon, Zacary P., Sillar, Jonathan R., McLachlan, Tabitha, Schjenken, John E., Skerrett-Byrne, David A., Huang, Honggang, Melo-Braga, Marcella N., Plank, Maximillan W., Alvaro, Frank, Chamberlain, Janis, De Iuliis, Geoff, Aitken, R. John, Mannan, Abdul, Nixon, Brett, Wei, AH, Enjeti, Anoop K., Huang, Y, Lock, RB, Larsen, MR, Lee, Heather, Vaghjiani, V, Cain, JE, de Bock, CE, Duchatel, Ryan J., Verrills, Nicole M., Dun, Matthew D., Staudt, Dilana, Murray, Heather C., Findlay, Izac J., Jackson, Evangeline R., McEwen, Holly P., Douglas, Alicia M.

Synergistic Targeting of DNA-PK and KIT Signaling Pathways in KIT Mutant Acute Myeloid Leukemia

- Murray, Heather C., Miller, Kasey, Brzozowski, Joshua S., Kahl, Richard G. S., Smith, Nathan D., Humphrey, Sean J., Dun, Matthew D., Verrills, Nicole M.

Elucidation of the protein composition of mouse seminal vesicle fluid

- Smyth, Shannon P., Nixon, Brett, Anderson, Amanda L., Murray, Heather C., Martin, Jacinta H., MacDougall, Lily A., Robertson, Sarah A., Skerrett-Byrne, David A., Schjenken, John E.

Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection

- Staudt, Dilana E., Murray, Heather C., Findlay, Izac J., Kearney, Padraic S., Mannan, Abdul, McEwen, Holly P., Douglas, Alicia M., Nixon, Brett, Verrills, Nicole M., Dun, Matthew D., Skerrett-Byrne, David A., Smith, Nathan D., Jamaluddin, M. Fairuz B., Kahl, Richard G. S., Duchatel, Ryan J., Germon, Zacary P., McLachlan, Tabitha, Jackson, Evangeline R.

Time-resolved proteomic profiling of cigarette smoke-induced experimental chronic obstructive pulmonary disease

- Skerrett-Byrne, David A., Bromfield, Elizabeth G., Anderson, Amanda L., Nixon, Brett, Scott, Rodney J., Wark, Peter A. B., Dun, Matthew D., Hansbro, Philip M., Murray, Heather C., Jamaluddin, M. Fairuz B., Jarnicki, Andrew G., Fricker, Michael, Essilfie, Ama T., Jones, Bernadette, Haw, Tatt J., Hampsey, Daniel

Shwachman-Bodian-Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia

- Dun, Matthew D., Mannan, Abdul, Germon, Zacary, Faulkner, Sam, Chi, Mengna, Skerrett-Byrne, David, Murray, Heather C., Flanagan, Hayley, Almazi, Juhura G., Hondermarck, Hubert, Nixon, Brett, De Iuliis, Geoff, Rigby, Callum J., Chamberlain, J, Alvaro, F, de Bock, CE, Morris, JC, Enjeti, Anoop K., Verrills, Nicole M., Butler, Stephen, Toop, Hamish D., Beck, Dominik, Connerty, Patrick, Sillar, Jonathan, Kahl, Richard G. S., Duchatel, Ryan J.

Targeting Oncogenic Signaling in Mutant FLT3 Acute Myeloid Leukemia: The Path to Least Resistance

- Staudt, Dilana, Murray, Heather C., McLachlan, Tabitha, Alvaro, Frank, Enjeti, Anoop K., Verrills, Nicole M., Dun, Matthew D.

Harnessing the power of proteomics for identification of oncogenic, druggable signalling pathways in cancer

- Murray, Heather C., Dun, Matthew D., Verrills, Nicole M.

Nucleotide excision repair deficiency in melanoma in response to UVA

- Murray, Heather C., Maltby, Vicki E., Smith, Doug W., Bowden, Nikola A.

Regulators of global genome repair do not respond to DNA damaging therapy but correlate with survival in melanoma

- Bowden, Nikola A., Ashton, Katie A., Scott, Rodney J., Vilain, Ricardo E., Avery-Kiejda, Kelly A., Davey, Ryan J., Murray, Heather C., Budden, Timothy, Braye, Stephen G., Zhang, Xu Dong, Hersey, Peter